logo

For the Inventor, By the Inventor

Raleigh, NC, United States of America

Robert W Morrison, Jr

This inventor holds 14 USPTO granted patents. Top assignee: Burroughs Wellcome Co.. Active years: 1980-1995.

USPTO Granted Patents = 14

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal14 out of 521 
 
Burroughs Wellcome Co.
 patents

Years Active: 1980-1995

Loading Chart...
14 patents (USPTO):Explore Patents
1. 5393883 - Antiviral combinations and compounds therefor (1995-02-28),
2. 5175165 - Antiviral combinations and compounds therefor (1992-12-29),
3. 4329362 - 2-Amino-4-(substituted hydrazino)-6-oxo pyrimidines (1982-05-11),
4. 4323679 - Pyrimido(4,5-c)pyridazines (1982-04-06),
5. 4315932 - Method of using 1H-pyrimido-4,5-c -1,2-diazepines as antibacterial and (1982-02-16),
6. 4303790 - 2-Amino-4-imino-6-hydrazinopyrimidine (1981-12-01),
7. 4303789 - 2-Amino-4-(substituted hydrazino)-6-imino pyrimidines (1981-12-01),
8. 4302587 - 6-(1-Methylhydrazino)isocytosine (1981-11-24),
9. 4288365 - Pyrido derivatives (1981-09-08),
10. 4260758 - Pyrazolo (3,4-d) pyrimidines and methods of making (1981-04-07),
11. 4255427 - Substituted pyrimido (4,5-c)pyridazines (1981-03-10),
12. 4237289 - 2,7-Diamino-8-methyl-5-substituted pyrido{2,3-d}pyrimidin-6-ones (1980-12-02),
13. 4235905 - 1H-Pyrimido[4,5-c]-1,2-diazepines (1980-11-25),
14. 4225710 - Pyrimido(4,5-c)pyridazines (1980-09-30),

Title: **The Innovative Contributions of Robert W. Morrison, Jr.**

Introduction

Robert W. Morrison, Jr. is a prominent inventor based in Raleigh, NC, with a remarkable portfolio of 14 patents. His work primarily focuses on significant advancements in antiviral therapies, particularly those targeting viruses of the herpes group. With a solid foundation in research and development, Morrison's contributions have made substantial impacts in the field of pharmacology.

Latest Patents

Morrison's latest inventions center around antiviral combinations and compounds. One noteworthy patent details novel ribonucleotide reductase inhibitors and innovative combinations that include antiviral compounds such as acyclovir and a thiocarbonohydrazone ribonucleotide reductase inhibitor. This opening of new avenues for chemotherapeutic treatments addresses the challenges posed by various viral infections, especially those related to herpes.

Career Highlights

Throughout his career, Morrison has made significant strides within the pharmaceutical sector, particularly during his tenure at Burroughs Wellcome Co. His dedication to enhancing antiviral therapies showcases his commitment to improving healthcare outcomes for patients with viral infections. The wealth of knowledge he possesses in the field underscores the importance of continued innovation in medical research.

Collaborations

In his journey of discovery, Morrison has collaborated with several esteemed colleagues in his field, notably Virgil L. Styles and William R. Mallory. Together, they have contributed to the development of groundbreaking therapies, emphasizing the importance of teamwork in driving scientific advancements.

Conclusion

Robert W. Morrison, Jr. stands out as a key figure in the realm of antiviral research and invention. His extensive patent portfolio reflects his innovative spirit and dedication to developing effective treatments for viral infections. With ongoing efforts and collaborations, Morrison continues to pave the way for future innovations in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…